ArticlePloS one2022

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.

Bernadette A M Heemskerk-Gerritsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.